ICF-based biopsychosocial hand OA assessment with AI profile prediction
Official title: ICF-Based Biopsychosocial Assessment With Artificial Intelligence-Assisted Profile Prediction: Trapeziometacarpal Osteoarthritis Model
Run by Hacettepe University · NCT07458971 · Data updated 2026-11-12
This observational study tests a biopsychosocial assessment for people with trapeziometacarpal osteoarthritis and uses AI to help predict patient profiles.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 25 Years to 74 Years |
| Sex | All |
| Enrollment | 93 (estimated) |
| Sponsor | Hacettepe University Academic / other |
| Locations | 1 site (Ankara) |
| Status | Recruiting |
| Started | February 19, 2026 |
| Main results expected | October 2026 |
| Study ends | February 2027 |
| Registry record updated | September 16, 2026 |
| Trial ID | NCT07458971 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 25–74 with diagnosed TMC OA, fluent in Turkish, and with sufficient cognitive function.
✕Probably not a fit
Individuals not experiencing benefit may be those with comorbid conditions or anxiety/depression severe enough to affect participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will use the ICF framework to comprehensively assess adults with trapeziometacarpal osteoarthritis, covering body structure/function, daily activities, participation, personal factors, and environmental factors. The study also compares how four large language models perform when answering patient questions under different prompting conditions, with expert reviewers rating accuracy and relevance. The design includes a cross-sectional data collection and an evaluation of AI knowledge across two prompts to gauge potential clinical usefulness. Participation requires Turkish literacy, adequate cognitive function, and confirmed TMC OA without certain exclusions.
Why it matters
Potential benefit: If successful, the study could improve understanding of how biopsychosocial factors influence TMC OA and inform AI-assisted patient-facing tools.
How similar studies have gone: Previous work has explored ICF-based assessments in musculoskeletal conditions, but applying AI-Language Model evaluation to patient questions in TMC OA is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of trapeziometacarpal osteoarthritis (TMC OA) confirmed by an orthopedic surgeon and/or hand surgeon * TMC OA-related symptoms persisting for more than 3 months * Aged between 25 and 74 years * Literate in Turkish * Adequate cognitive function (Mini-Mental State Examination score of 25 or above) * No other chronic systemic disease (e.g., rheumatoid arthritis, chronic diabetes, cardiovascular disease, chronic hepatitis) * Voluntary participation with signed informed consent Exclusion Criteria: * Unwillingness to participate * Presence of a different orthopedic condition or prior surgery involving the thumb on the unilateral upper extremity * Uncontrolled systemic diseases (chronic obstructive pulmonary disease, congestive heart failure, endocrine system disease, history of stroke) * Diagnosis of any major psychopathology and currently receiving psychiatric or psychological treatment * Pregnancy
Where it's running
-
Hacettepe University, Faculty of Physical Therapy and Rehabilitation, Hand Surgery Rehabilitation Unit
Ankara, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Tugba Ulusoy, MSc
- Email: tugbaulusoy1@gmail.com
- Phone: +90 5075097351
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Thumb base arthritis: joint replacement vs trapeziectomy
This trial tests whether a total thumb joint replacement (TOUCH prosthesis) works as well as trapeziectomy for people with basal thumb arthritis.
-
High-energy laser treatment for thumb osteoarthritis (rhizarthrosis)
This trial will test whether high-energy laser therapy using the THEAL Ixyon XP can reduce pain and improve function in people with early-stage thumb base osteoarthritis.
-
PRP Injection for Thumb Base Osteoarthritis (CMC-I) to See if It Reduces Pain
A PRP injection into the thumb base joint is being tested against a saline injection to see if it lowers pain and improves hand function for adults with thumb base osteoarthritis.
-
Thumb position sense in base-of-thumb (trapeziometacarpal) osteoarthritis
It tests whether people with base-of-thumb (trapeziometacarpal) osteoarthritis sense their thumb's position and movement differently than people without the condition.
-
Thumb Base Joint OA: Using a treated umbilical cord membrane as an interposed implant
This trial tests whether placing a processed human umbilical cord amniotic membrane inside the trapeziometacarpal joint during surgery can reduce pain and improve thumb motion and strength in people with thumb-base osteoarthritis.
-
Isolated thumb‑base (trapeziometacarpal) joint arthroplasty with double‑mobility for peritrapezial osteoarthritis in 300 patients
This trial will try an isolated double‑mobility thumb‑base joint replacement to see if it improves pain and hand function in adults with trapeziometacarpal osteoarthritis who need surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.